Search - tctmd.com

Displaying 1 - 20 of 31

Sort: Relevancy | Date

News Industry News

Efemoral Medical Announces Successful First-In-Human Use of The Efemoral™ Vascular Scaffold System

December 14, 2020

No Angina? No Benefit to PCI Pre-TAVR: ACTIVATION

Shelley Wood

November 26, 2020

News Conference News AHA 2020

Clopidogrel Should Remain Antiplatelet of Choice in Elective PCI: ALPHEUS

Michael O'Riordan

November 14, 2020

News Conference News VIVA 2020

BVS Reboot? Signs of Durability to 2 Years in Critical Limb-Threatening Ischemia

L.A. McKeown

November 11, 2020

News Conference News VIVA 2020

DISRUPT PAD III: Lithotripsy Shows Promise in Heavily Calcified PAD

L.A. McKeown

November 09, 2020

News Conference News TCT 2020

While Rare, Surgical Removal of TAVR Carries Risks: Global EXPLANT-TAVR Registry

L.A. McKeown

October 21, 2020

Direct Temsirolimus Delivery Shows Promise in BTK: Phase II Study

News Conference News TCT 2020

Direct Temsirolimus Delivery Promising in BTK: TANGO Phase II Study

Caitlin E. Cox

October 18, 2020

News Conference News TCT 2020

OPTIMIZE: Svelte Direct Stenting Device Fails to Match DES

L.A. McKeown

October 17, 2020

News Conference News TCT 2020

IVUS-Guided PCI Gains Support With Longer-Term ULTIMATE Results

Todd Neale

October 15, 2020

News Conference News TCT 2020

DISRUPT CAD III: Lithotripsy Boosts Stent Expansion in Highly Calcified Lesions

L.A. McKeown

October 15, 2020

News Conference News TCT 2020

Delays, Deaths, and More Cardiogenic Shock Among ACS Patients With COVID-19

Todd Neale

October 14, 2020

News Conference News TCT 2020

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

Michael O'Riordan

October 14, 2020

News Daily News

Features of Complex CAD Carry Progressive Risk in PCI, Registry Confirms

Caitlin E. Cox

October 08, 2020

In-Stent Restenosis Accounts for 10% of All PCIs, Contemporary National Analysis Shows

News Daily News

In-Stent Restenosis Accounts for 10% of All PCIs, National Analysis Shows

L.A. McKeown

September 24, 2020

News Daily News

Registry Supports Paclitaxel DCBs in CLI Patients to 2 Years

L.A. McKeown

September 17, 2020

News Daily News

Better Outcomes, Including Mortality, With IVUS-Guided PCI: Medicare Analysis

Michael O'Riordan

August 18, 2020

News Daily News

Thrombus Burden Greater in STEMI Patients With COVID-19

Michael O'Riordan

July 20, 2020

News Daily News

Black Patients in RCTs of PCI Show Worse Long-term Outcomes

Caitlin E. Cox

July 10, 2020

News Daily News

STEMI Spectrum in COVID-19 Captured by Multinational Case Series

Caitlin E. Cox

July 08, 2020

News Conference News EuroPCR 2020

DynamX Bioadaptor Provides Promising Preliminary Results for De Novo Coronary Lesions

Todd Neale

June 30, 2020

Advertisement

Efemoral Medical Announces Successful First-In-Human Use of The Efemoral™ Vascular Scaffold System

No Angina? No Benefit to PCI Pre-TAVR: ACTIVATION

Clopidogrel Should Remain Antiplatelet of Choice in Elective PCI: ALPHEUS

BVS Reboot? Signs of Durability to 2 Years in Critical Limb-Threatening Ischemia

DISRUPT PAD III: Lithotripsy Shows Promise in Heavily Calcified PAD

While Rare, Surgical Removal of TAVR Carries Risks: Global EXPLANT-TAVR Registry

Direct Temsirolimus Delivery Promising in BTK: TANGO Phase II Study

OPTIMIZE: Svelte Direct Stenting Device Fails to Match DES

IVUS-Guided PCI Gains Support With Longer-Term ULTIMATE Results

DISRUPT CAD III: Lithotripsy Boosts Stent Expansion in Highly Calcified Lesions

Delays, Deaths, and More Cardiogenic Shock Among ACS Patients With COVID-19

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

Features of Complex CAD Carry Progressive Risk in PCI, Registry Confirms

In-Stent Restenosis Accounts for 10% of All PCIs, National Analysis Shows

Registry Supports Paclitaxel DCBs in CLI Patients to 2 Years

Better Outcomes, Including Mortality, With IVUS-Guided PCI: Medicare Analysis

Thrombus Burden Greater in STEMI Patients With COVID-19

Black Patients in RCTs of PCI Show Worse Long-term Outcomes

STEMI Spectrum in COVID-19 Captured by Multinational Case Series

DynamX Bioadaptor Provides Promising Preliminary Results for De Novo Coronary Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content